Novel B7-H3 CAR T cells show potent antitumor effects in glioblastoma: a preclinical study
Journal for ImmunoTherapy of Cancer · 2025-01 · 13 (1) · e010083
DOI: 10.1136/jitc-2024-010083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 25.01.2025. Verfasst von Thananya Inthanachai und 12 weiteren Autor:innen. Beteiligte Einrichtung: Medical Microbiology, Interdisciplinary and International Program, Graduate School, Chulalongkorn University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Glioblastoma, B7 Antigens, Immunotherapy, Adoptive, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Council of Thailand, Thailand Science Research and Innovation Fund, The Program Management Unit for Human Resource & Institutional Development, Research and Innovation.
Abstract (Originalsprache)
Background
B7 homolog 3 (B7-H3), an overexpressed antigen across multiple solid cancers, represents a promising target for CAR T cell therapy. This study investigated the expression of B7-H3 across various solid tumors and developed novel monoclonal antibodies (mAbs) targeting B7-H3 for CAR T cell therapy.
Methods
Expression of B7-H3 across various solid tumors was evaluated using RNA-seq data from TCGA, TARGET, and GTEx datasets and by flow cytometry staining. B7-H3-specific mAbs were developed by immunizing mice with human B7-H3, screening with ELISA, and analyzing kinetics with surface plasmon resonance. These mAbs were used to create second-generation CAR constructs, which were evaluated in vitro and in vivo for their antitumor function.
Results
We identified four mAb clones from immunized mice, with three demonstrating high specificity and affinity. The second-generation B7-H3 CAR T cells derived from these mAbs exhibited robust cytotoxicity against B7-H3-positive targets and successfully infiltrated and eliminated tumor spheroids in vitro. In a xenograft mouse model of glioblastoma, these CAR T cells, particularly those derived from clone A2H4, eradicated the primary tumor, and effectively controlled rechallenge tumor, resulting in prolonged survival of the xenograft mice. In vivo T cell trafficking revealed high accumulation and persistence of A2H4-derived CAR T cells at the tumor site.
Conclusions
Our results provide novel B7-H3-targeted CAR T cells with high efficacy, paving the way for clinical translation of solid tumor treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Microbiology, Interdisciplinary and International Program, Graduate School, Chulalongkorn University, Bangkok, Thailand.
- Cellular Immunotherapy Research Unit, Chulalongkorn University, Bangkok, Thailand.
- Center of Excellence in Systems Biology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- Chulalongkorn Comprehensive Cancer Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
- Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
- Chulalongkorn University Laboratory Animal Center, Chulalongkorn University, Bangkok, Thailand.
Förderung
- National Research Council of Thailand
- Thailand Science Research and Innovation Fund
- The Program Management Unit for Human Resource & Institutional Development, Research and Innovation
- the Second Century Fund (C2F), Chulalongkorn University
- Development and Promotion of Science and Technology Talents (DPST) Project
Zitieren
APA
Inthanachai, T., Boonkrai, C., Phakham, T., Pisitkun, T., Thaiwong, R., Chuthaphakdikun, V., Sakunrangsit, N., Limprasutr, V., Chinsuwan, T., Hirankarn, N., Suppipat, K., Watanabe, N., & Tawinwung, S. (2025). Novel B7-H3 CAR T cells show potent antitumor effects in glioblastoma: a preclinical study. Journal for ImmunoTherapy of Cancer, 13(1), e010083. https://doi.org/10.1136/jitc-2024-010083
Vancouver
Inthanachai T, Boonkrai C, Phakham T, Pisitkun T, Thaiwong R, Chuthaphakdikun V, et al. Novel B7-H3 CAR T cells show potent antitumor effects in glioblastoma: a preclinical study. Journal for ImmunoTherapy of Cancer. 2025;13(1):e010083. doi:10.1136/jitc-2024-010083
BibTeX
@article{Inthanachai2025,
author = {Inthanachai, Thananya and Boonkrai, Chatikorn and Phakham, Tanapati and Pisitkun, Trairak and Thaiwong, Rattapoom and Chuthaphakdikun, Vichaya and Sakunrangsit, Nithidol and Limprasutr, Vudhiporn and Chinsuwan, Thanyavi and Hirankarn, Nattiya and Suppipat, Koramit and Watanabe, Norihiro and Tawinwung, Supannikar},
title = {Novel B7-H3 CAR T cells show potent antitumor effects in glioblastoma: a preclinical study},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2025},
volume = {13},
number = {1},
pages = {e010083},
doi = {10.1136/jitc-2024-010083}
}
EUVIMED